Universal Health Services (NYSE:UHS) Issues Quarterly Earnings Results

Universal Health Services (NYSE:UHS) announced its earnings results on Wednesday. The health services provider reported $3.70 EPS for the quarter, topping analysts’ consensus estimates of $3.12 by $0.58, Briefing.com reports. The firm had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Universal Health Services had a return on equity of 12.08% and a net margin of 5.03%. The company’s quarterly revenue was up 10.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.34 EPS.

Universal Health Services Trading Up 0.6 %

Shares of NYSE UHS opened at $165.84 on Thursday. The company has a quick ratio of 1.29, a current ratio of 1.40 and a debt-to-equity ratio of 0.77. The business has a fifty day simple moving average of $170.50 and a two-hundred day simple moving average of $153.01. The firm has a market cap of $11.15 billion, a PE ratio of 16.16, a price-to-earnings-growth ratio of 0.82 and a beta of 1.24. Universal Health Services has a twelve month low of $119.90 and a twelve month high of $183.61.

Insider Buying and Selling at Universal Health Services

In other Universal Health Services news, CFO Steve Filton sold 35,000 shares of Universal Health Services stock in a transaction on Friday, March 8th. The stock was sold at an average price of $176.82, for a total transaction of $6,188,700.00. Following the completion of the sale, the chief financial officer now directly owns 68,785 shares of the company’s stock, valued at approximately $12,162,563.70. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 16.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on UHS shares. Citigroup lifted their target price on Universal Health Services from $170.00 to $193.00 and gave the stock a “buy” rating in a report on Thursday, February 29th. Wells Fargo & Company lifted their target price on Universal Health Services from $195.00 to $200.00 and gave the stock an “overweight” rating in a report on Thursday, March 28th. UBS Group lifted their target price on Universal Health Services from $152.00 to $177.00 and gave the stock a “neutral” rating in a report on Thursday, February 29th. JPMorgan Chase & Co. lifted their target price on Universal Health Services from $144.00 to $182.00 and gave the stock a “neutral” rating in a report on Wednesday, March 13th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Universal Health Services from $208.00 to $203.00 and set a “buy” rating for the company in a report on Friday, April 12th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $179.71.

Universal Health Services Company Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.